People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

The costs for 806 patients with overweight or obesity and heart failure were analyzed in one study. For those patients, the average total medical costs dropped from $29,654 before treatment began to ...

Drawing inferences from observational data with possible confounding Heart failure is increasing in prevalence and is a major cause of morbidity and mortality worldwide,1 with prevalence ranging from ...

Committee members said there was uncertainty around sotagliflozin in patients with kidney disease. The FDA is currently ...

On Halloween, Lexicon was haunted again as an FDA advisory committee voted 11-3 to reject Zynquista as an accompanying ...

Lexicon Pharmaceuticals shares have been halted all day as a Food and Drug Administration advisory committee was scheduled to vote on Zynquista as an adjunct to insulin therapy for glycemic control in ...

FDA staff raised familiar safety concerns about sotagliflozin as a treatment for type 1 diabetes (T1D) as the agency again ...

In none of the patients was there evidence of any associated etiologic factor such as coronary-artery disease, rheumatic heart disease, hypertension or thyrotoxicosis. Table 3 Types of Pulmonary ...

Congestive heart failure (CHF) is the term used to describe what happens when the heart is unable to pump enough blood to meet the body’s needs. (It should not be confused with cardiac arrest in which ...

The Rio Grande Valley has elevated rates of diabetes, heart failure and other chronic conditions ... Singh died of diabetes ...

Filipino celebrity Heart Evangelista, a renowned resident of fashion weeks around the globe, was spotted in Dubai on Friday night. The socialite, who is also a senator’s wife, shared a candid ...

Although glucagon-like peptide-1-receptor agonists have been linked to acute kidney injury in prior studies, a recent analysis found no such association in patients with cancer who were taking these ...